human insulin + insulin analogue

This drug is a combination of human insulin and an insulin analogue, used primarily for the management of diabetes mellitus. Human insulin is a recombinant form identical to endogenous human insulin, while insulin analogues are genetically modified forms designed to alter pharmacokinetic properties such as onset and duration of action. The combination aims to provide both rapid-acting and prolonged glucose-lowering effects, mimicking physiological patterns of endogenous insulin secretion more closely than single-component formulations. These combinations are typically administered subcutaneously and can be found in premixed preparations that combine short- or rapid-acting with intermediate- or long-acting insulins. The mechanism involves binding to the insulin receptor on target tissues (liver, muscle, adipose), promoting glucose uptake from the bloodstream and inhibiting hepatic glucose production[1][3][4][5].

Brand names

Humalog Mix25/50/75NovoMix